Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-06-21
DOI
10.1093/cid/ciz546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C
- (2018) A. J. Wade et al. JOURNAL OF VIRAL HEPATITIS
- Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial
- (2018) A. J. Wade et al. Trials
- Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017
- (2018) Jeffrey V Lazarus et al. Journal of the International AIDS Society
- Decline in new HIV diagnoses among MSM in Melbourne
- (2018) Eric P F Chow et al. Lancet HIV
- National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
- (2017) W. El-Akel et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C: global epidemiology and strategies for control
- (2016) S. Lanini et al. CLINICAL MICROBIOLOGY AND INFECTION
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
- (2015) Soumitri Barua et al. ANNALS OF INTERNAL MEDICINE
- The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service
- (2015) Amanda J. Wade et al. PLoS One
- Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries
- (2014) A. Hill et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)
- (2014) G. J. Dore et al. JOURNAL OF VIRAL HEPATITIS
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- (2014) Ira M Jacobson et al. LANCET
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
- (2011) Paul K Nelson et al. LANCET
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now